AbbVie Inc.
ABBV
$236.19
$2.331.00%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.62B | 15.78B | 15.42B | 13.34B | 15.10B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.62B | 15.78B | 15.42B | 13.34B | 15.10B |
| Cost of Revenue | 4.55B | 4.46B | 4.35B | 4.00B | 4.22B |
| Gross Profit | 12.07B | 11.32B | 11.08B | 9.34B | 10.89B |
| SG&A Expenses | 3.82B | 3.43B | 3.18B | 3.21B | 3.69B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 0.00 | -- | -24.00M | -- | -7.00M |
| Total Operating Expenses | 10.95B | 10.18B | 9.64B | 9.28B | 10.19B |
| Operating Income | 5.67B | 5.60B | 5.79B | 4.06B | 4.91B |
| Income Before Tax | 2.67B | 714.00M | 1.55B | 1.66B | -2.27B |
| Income Tax Expenses | 853.00M | 526.00M | 613.00M | 372.00M | -2.25B |
| Earnings from Continuing Operations | 1.82B | 188.00M | 941.00M | 1.29B | -23.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | -2.00M | -3.00M | -3.00M | 1.00M |
| Net Income | 1.82B | 186.00M | 938.00M | 1.29B | -22.00M |
| EBIT | 5.67B | 5.60B | 5.79B | 4.06B | 4.91B |
| EBITDA | 7.66B | 7.66B | 7.84B | 6.10B | 7.01B |
| EPS Basic | 1.02 | 0.10 | 0.52 | 0.72 | -0.02 |
| Normalized Basic EPS | 1.81 | 1.81 | 1.83 | 1.21 | 1.53 |
| EPS Diluted | 1.02 | 0.10 | 0.52 | 0.72 | -0.02 |
| Normalized Diluted EPS | 1.81 | 1.80 | 1.83 | 1.21 | 1.53 |
| Average Basic Shares Outstanding | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B |
| Average Diluted Shares Outstanding | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B |
| Dividend Per Share | 1.73 | 1.64 | 1.64 | 1.64 | 1.64 |
| Payout Ratio | 160.30% | 1,565.05% | 310.23% | 227.45% | -12,509.09% |